Brainstorm completes stem cell bioreactor

Israel’s BrainStorm, together with Canadian company Octane Biotech, has built a bioreactor for commercial production of the stem cells used as a basis for the company’s treatment for ALCS. The ability to multiply stem cells is critical for the treatment’s success.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *